$3.16
-0.14-4.24%
At Close: -
$3.01
-0.15-4.75%
After Hours: Sep 20, 7:59 PM EDT
15 minutes delayed
Sunshine Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sunshine Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-16 | $-9.94 | $-7.40 | -34.3 % |
Mar 2024 | 2024-05-20 | $-40.00 | $-160.00 | 75.0 % |
Dec 2023 | 2024-03-28 | $-120.00 | $-60.00 | -100.0 % |
Sep 2023 | 2023-11-13 | $-80.00 | $-120.00 | 33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-16 | $9.30M | $9.00M | 3.37 % |
Mar 2024 | 2024-05-20 | $7.54M | $7.00M | 7.73 % |
Dec 2023 | 2024-03-28 | $7.68M | $6.10M | 25.9 % |
Sep 2023 | 2023-11-13 | $5.60M | $6.00M | -6.70 % |
Sunshine Biopharma (SBFM) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 16, 2024 for Q2.
The Actual EPS was $-9.94, which missed the estimate of $-7.40.
The Actual Revenue was $9.3M, which beat the estimate of $9M.
Browse earnings estimates, EPS, and revenue on all stocks.